521 related articles for article (PubMed ID: 26405286)
1. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go UY; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M
Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286
[TBL] [Abstract][Full Text] [Related]
2. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
Cui X; Gao L; Cao B
Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases.
Lee CK; Wong SHV; Lui G; Tang W; Tam LS; Ip M; Hung E; Chen M; Wu JC; Ng SC
J Crohns Colitis; 2018 Jul; 12(8):954-962. PubMed ID: 29757355
[TBL] [Abstract][Full Text] [Related]
4. Advances in diagnosis and treatment of latent tuberculosis infection.
Chapman HJ; Lauzardo M
J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
[TBL] [Abstract][Full Text] [Related]
5. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
[TBL] [Abstract][Full Text] [Related]
6. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
[TBL] [Abstract][Full Text] [Related]
7. Progress on diagnosis and treatment of latent tuberculosis infection.
Ying C; He C; Xu K; Li Y; Zhang Y; Wu W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 51(6):691-696. PubMed ID: 36915977
[TBL] [Abstract][Full Text] [Related]
8. Updates on the risk factors for latent tuberculosis reactivation and their managements.
Ai JW; Ruan QL; Liu QH; Zhang WH
Emerg Microbes Infect; 2016 Feb; 5(2):e10. PubMed ID: 26839146
[TBL] [Abstract][Full Text] [Related]
9. Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort.
Chiang LY; Baumann B; Romanowski K; Kumar D; Campbell JR; Djurdjev O; Morshed M; Sekirov I; Cook VJ; Levin A; Johnston JC
Am J Kidney Dis; 2021 May; 77(5):696-703. PubMed ID: 32818551
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis: Common Questions and Answers.
Hartman-Adams H; Gerbo RM; George S
Am Fam Physician; 2022 Sep; 106(3):308-315. PubMed ID: 36126013
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients.
Okada RC; Barry PM; Skarbinski J; Chitnis AS
Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1367-1374. PubMed ID: 30231948
[TBL] [Abstract][Full Text] [Related]
13. Latent tuberculosis infection: Opportunities and challenges.
Chee CBE; Reves R; Zhang Y; Belknap R
Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
[TBL] [Abstract][Full Text] [Related]
14. National position statement for the management of latent tuberculosis infection.
Stock D;
Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
[TBL] [Abstract][Full Text] [Related]
15. Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
Harries AD; Kumar AMV; Satyanarayana S; Takarinda KC; Timire C; Dlodlo RA
Expert Rev Respir Med; 2020 Feb; 14(2):195-208. PubMed ID: 31760848
[No Abstract] [Full Text] [Related]
16. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
Nisar MK; Rafiq A; Östör AJ
Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
19. Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center.
Arguello Perez E; Seo SK; Schneider WJ; Eisenstein C; Brown AE
Clin Infect Dis; 2017 Nov; 65(12):2105-2111. PubMed ID: 29020308
[TBL] [Abstract][Full Text] [Related]
20. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
